{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:05:11Z","timestamp":1784401511591,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":5977,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1111\/j.1538-7836.2006.02031.x","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T07:13:05Z","timestamp":1153897985000},"page":"1798-1803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The 4G\/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin"],"prefix":"10.1016","volume":"4","author":[{"given":"C.","family":"RONCAL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"ORBE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"BELZUNCE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"RODR\u00edGUEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"P\u00c1RAMO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0015","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0020","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.0000091250.53231.4D","article-title":"Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis","volume":"23","author":"Sobel","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bmj.291.6495.573","article-title":"Plasminogen activator inhibitor in the blood of patients with coronary artery disease","volume":"291","author":"P\u00e1ramo","year":"1985","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction","volume":"ii","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0035","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/01.CIR.103.25.3105","article-title":"Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice","volume":"103","author":"Zhu","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.ATV.19.1.39","article-title":"On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells","volume":"19","author":"Arts","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0045","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/diabetes.48.4.890","article-title":"Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue","volume":"48","author":"Morange","year":"1999","journal-title":"Diabetes"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1124\/jpet.103.054346","article-title":"Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells","volume":"307","author":"Hamaguchi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0055","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbrc.2003.09.091","article-title":"Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro","volume":"310","author":"He","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0060","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1111\/j.1742-4658.2005.04979.x","article-title":"Induction of PAI-1 expression by tumor necrosis factor \u03b1 in endothelial cells is mediated by its responsive element located in the 4G\/5G site","volume":"272","author":"Swiatkowska","year":"2005","journal-title":"FEBS J"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","article-title":"Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk","volume":"91","author":"Hoekstra","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-0038-1657569","article-title":"Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis","volume":"78","author":"Humphries","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0075","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0080","first-page":"306","article-title":"Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha","volume":"84","author":"Orbe","year":"1999","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0085","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cardiores.2004.03.023","article-title":"Influence of the 4G\/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension","volume":"63","author":"Roncal","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0100","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9150(00)00454-8","article-title":"Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells","volume":"152","author":"Lopez","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0037-1613968","article-title":"Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells","volume":"84","author":"Mussoni","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1254\/jjp.90.337","article-title":"Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity","volume":"90","author":"Swiatkowska","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.ATV.18.2.152","article-title":"The PAI-1 gene locus 4G\/5G polymorphism is associated with a family history of coronary artery disease","volume":"18","author":"Margaglione","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0049-3848(02)00254-2","article-title":"The 4G\/5G-polymorphism in the PAI-1 gene is not associated with markers of atherosclerosis in male smokers","volume":"107","author":"Hoekstra","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0049-3848(98)00132-7","article-title":"The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G\/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells","volume":"92","author":"McCormack","year":"1998","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0135","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0268-9499(95)80007-7","article-title":"Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene","volume":"9","author":"Falk","year":"1995","journal-title":"Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0145","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.ATV.20.6.1682","article-title":"Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes","volume":"20","author":"Birgel","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0037-1613596","article-title":"Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G\/5G polymorphism of the PAI-1 gene","volume":"90","author":"Nordt","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0155","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJMx060007","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"354","author":"Cannon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0160","doi-asserted-by":"crossref","first-page":"4B","DOI":"10.1016\/S0002-9149(02)03267-8","article-title":"Mechanisms of plaque stabilization with statins","volume":"91","author":"Libby","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0165","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins","volume":"83","author":"Essig","year":"1998","journal-title":"Circ Res"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.20.2.556","article-title":"HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells","volume":"20","author":"Bourcier","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-4889(02)00201-X","article-title":"Inhibition of Rho\/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes","volume":"1590","author":"Ishibashi","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcb.10602","article-title":"Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells","volume":"90","author":"Markle","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells","volume":"23","author":"Dichtl","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0704678","article-title":"Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ","volume":"136","author":"Wagner","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1538-7836.2006.02031.x_bb0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00365519709084594","article-title":"Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G\/5G polymorphism in the PAI-1 gene","volume":"57","author":"Nordenhem","year":"1997","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.02031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.02031.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:38:56Z","timestamp":1761532736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622175331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1538783622175331"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02031.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 4G\/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02031.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}